AMN Stock Cash Flow Statements

AMN Healthcare Services Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

AMN Healthcare Services Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31

cash flows from operating activities:
net income	-116,202,000	-1,092,000	-187,533,000	6,989,000	16,237,000	17,328,000	12,489,000	53,174,000	60,906,000	84,110,000	81,797,000	92,445,000	123,800,000	146,008,000	116,217,000	74,023,000	66,770,000	70,378,000	9,308,000	26,067,000	22,325,000	12,965,000	27,482,000	23,515,000	28,869,000	34,122,000	35,613,000	27,918,000	35,529,000	42,681,000	41,167,000	28,128,000	31,255,000	32,008,000	26,351,000	27,296,000	26,322,000	25,869,000	20,165,000	33,647,000	15,870,000	12,209,000	9,895,000	8,499,000	7,193,000	7,630,000	8,356,000	8,615,000	8,399,000	7,563,000	7,083,000	5,858,000	-81,000	4,276,000	-2,435,000	-26,899,000	813,000	2,256,000	-1,618,000	-51,290,000	137,000	780,000	-2,722,000	-1,995,000	4,374,000	-121,834,000	7,624,000	7,850,000	9,367,000	9,516,000	9,004,000	10,088,000	9,246,000	8,194,000	10,047,000	9,472,000	7,271,000	8,301,000	6,977,000	6,848,000	4,416,000	3,993,000	4,534,000	3,930,000	4,917,000	9,286,000	11,190,000	12,399,000	14,406,000	14,292,000	12,481,000	11,177,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	39,885,000	39,857,000	41,474,000	43,050,000	44,738,000	44,517,000	43,132,000	40,727,000	38,234,000	38,834,000	38,024,000	34,330,000	33,247,000	31,510,000	27,826,000	26,790,000	25,356,000	23,725,000	24,110,000	27,417,000	22,426,000	20,234,000	17,007,000	17,085,000	12,718,000	11,710,000	11,449,000	11,296,000	10,606,000	7,886,000	8,520,000	8,132,000	7,959,000	7,668,000	7,732,000	7,789,000	7,334,000	6,765,000	5,322,000	5,304,000	5,232,000	5,095,000	4,077,000	4,086,000	4,010,000	3,820,000	3,698,000	3,317,000	3,240,000	3,290,000	3,469,000	3,435,000	3,552,000	3,695,000	3,878,000	3,954,000	4,119,000	4,465,000	4,836,000	3,787,000	3,163,000	3,298,000	3,408,000	3,495,000	3,442,000	3,467,000	3,581,000	3,770,000	3,738,000	3,350,000	3,209,000	2,979,000	2,857,000	2,629,000	2,697,000	2,638,000	2,524,000	2,466,000	2,162,000	1,481,000	1,457,000	1,079,000	1,411,000	1,425,000	1,351,000	1,203,000	1,150,000	1,115,000	1,302,000	935,000
non-cash interest expense and other	609,000	608,000	10,309,000	534,000	533,000	534,000	7,234,000	549,000	533,000	505,000	3,903,000	474,000	474,000	479,000	474,000	-4,290,000	510,000	-761,000	622,000	910,000	906,000	1,911,000	168,000	682,000	591,000	543,000	-5,432,000	-686,000	677,000	600,000	513,000	597,000	542,000	579,000	1,236,000	455,000	149,000	576,000	489,000	454,000	534,000	457,000	288,000	428,000	381,000	295,000
increase in allowance for credit losses and sales credits	3,564,000	2,182,000	-2,260,000	-2,371,000	7,539,000	388,000	-8,055,000	2,536,000	3,985,000	25,447,000	35,800,000	8,396,000	10,371,000	3,432,000	4,160,000	2,629,000	-4,917,000	4,391,000	-1,045,000	838,000	2,007,000	4,735,000
benefit from deferred income taxes	-27,938,000	-5,824,000	-45,159,000	-3,307,000	5,060,000	-7,661,000	-21,428,000	24,275,000	-9,141,000	-6,639,000	-19,251,000	-8,785,000	-15,105,000	18,526,000	-11,959,000	-2,938,000	-3,318,000	1,928,000	-3,705,000	-8,096,000	-10,560,000	733,000	4,613,000	6,628,000	-1,292,000	-9,036,000	1,717,000	4,789,000	-2,060,000	-5,113,000	15,119,000	-488,000	-4,124,000	-4,900,000	-6,215,000	-2,790,000	782,000	-1,201,000	-5,006,000	11,454,000	870,000	5,359,000	10,011,000	2,842,000	-2,959,000	1,885,000	1,080,000	1,089,000	-161,000	1,023,000	2,504,000	3,120,000	-1,733,000	3,060,000	-1,100,000	-1,230,000	-803,000	1,338,000	-1,265,000	-8,678,000	21,000	-789,000	2,494,000	-2,612,000	-2,029,000	-49,574,000	-1,165,000	-823,000			-1,480,000	3,437,000	-1,709,000	892,000	5,415,000	5,254,000	1,913,000	5,495,000	15,504,000	1,549,000	1,346,000	618,000	-1,050,000	3,408,000					7,243,000
share-based compensation	8,827,000	9,381,000	3,666,000	5,555,000	6,357,000	7,739,000	2,578,000	306,000	4,818,000	10,318,000	5,396,000	4,898,000	8,513,000	11,259,000	7,322,000	2,589,000	6,019,000	9,287,000	5,419,000	3,772,000	6,347,000	4,927,000	4,528,000	2,825,000	3,702,000	5,186,000	2,861,000	1,809,000	3,281,000	2,864,000	2,517,000	2,477,000	2,562,000	2,681,000	2,604,000	2,704,000	2,710,000	3,381,000	3,733,000	2,021,000	2,153,000	2,377,000	1,796,000	1,791,000	1,751,000	1,819,000	1,458,000	1,487,000
loss on disposal or impairment of long-lived assets	18,269,000	27,000	23,000	23,000	9,000	10,000	6,260,000	-140,000	84,000	1,849,000
net gain on investments in available-for-sale securities											97,000	116,000
goodwill impairment loss
net gain on deferred compensation balances	561,000	502,000	-36,000	226,000	-1,034,000	-381,000	765,000	277,000	-618,000	41,000	798,000	-1,285,000	531,000	-570,000				370,000				-240,000
non-cash lease expense	13,000	28,000	-341,000	-313,000	209,000	-799,000	473,000	1,386,000	-12,000	-228,000	679,000	1,276,000	662,000	2,880,000	4,063,000	537,000	-365,000	-429,000	-833,000	64,000	359,000	-179,000	6,000	105,000	-14,000	-92,000
changes in assets and liabilities, net of effects from acquisitions:
accounts receivable	26,894,000	13,766,000	13,269,000	60,222,000	61,369,000	41,367,000	-7,539,000	11,666,000	103,282,000	-37,376,000	13,389,000	48,067,000	190,509,000	-194,044,000	-223,191,000	-104,431,000	99,360,000	-191,271,000	-22,489,000	12,991,000	7,946,000	-5,786,000	3,132,000	12,719,000	13,927,000	-1,500,000	-2,196,000	-13,087,000	4,676,000	9,154,000	-8,227,000	-10,271,000	-2,147,000	1,787,000	-16,106,000	-1,160,000	-26,215,000	-15,219,000	-28,921,000	-19,393,000	-10,896,000	-16,443,000	-22,442,000	-13,335,000	-2,375,000	-3,806,000	-3,542,000	3,834,000	6,406,000	-15,342,000	-2,113,000	-7,195,000	3,633,000	3,033,000	-4,163,000	-5,919,000	-2,265,000	-11,254,000	-1,818,000	-9,152,000	-23,000	-26,000	2,578,000	18,132,000	33,834,000	34,186,000	12,073,000	6,169,000	-277,000	-7,559,000	8,387,000	-515,000	-6,541,000	4,203,000	-12,993,000	-24,233,000	-5,038,000	1,665,000	-1,042,000	137,000	2,023,000	-1,592,000	-1,088,000	2,565,000	-3,930,000	216,000	17,350,000	3,743,000	-5,234,000	1,309,000
accounts receivable, subcontractor	6,205,000	5,174,000	-1,915,000	12,730,000	16,220,000	20,187,000	58,273,000	-7,745,000	108,424,000	-7,929,000	-14,772,000	-6,247,000	42,604,000	-50,592,000	-98,093,000	-11,217,000	7,958,000	-64,382,000	-17,685,000	2,169,000	17,469,000	-3,224,000	-9,961,000	-12,694,000	5,549,000	-5,465,000	-5,252,000	-10,234,000	4,370,000	1,985,000	-3,812,000	-569,000	12,207,000	395,000	-7,139,000	4,233,000	3,532,000	916,000	-1,287,000	-12,612,000	-2,718,000	-5,748,000	-6,874,000	943,000	-3,832,000	-409,000	598,000	-3,141,000	3,604,000	-865,000	1,219,000	2,310,000	1,344,000	-843,000	-5,056,000	-1,739,000	122,000	1,258,000	-1,304,000	3,982,000
income taxes receivable	-4,477,000	5,568,000	-409,000	56,000	-9,009,000	5,350,000	-5,082,000	0	0	8,875,000	-7,449,000	-404,000			1,119,000	681,000	-1,800,000	6,591,000	-6,569,000	0	173,000	5,984,000	-1,063,000	-1,728,000	-2,472,000	799,000	2,102,000	-989,000	4,105,000	9,881,000	-13,683,000	-1,029,000	-1,186,000	361,000	309,000	712,000	-558,000	6,006,000	6,859,000	-4,195,000	32,000	5,171,000									1,986,000	782,000	501,000	-234,000	-1,162,000	-196,000	1,257,000	489,000	-338,000	-756,000	69,000	1,165,000			3,023,000	-1,008,000												-2,677,000
prepaid expenses	5,936,000	-2,134,000	-5,438,000	2,600,000	4,254,000	-3,392,000	-1,886,000	-399,000	8,731,000	-7,988,000	-1,689,000	10,412,000	11,710,000	33,373,000	-53,093,000	-1,509,000	2,004,000	-6,190,000	2,019,000	-101,000	4,403,000	-7,663,000	-344,000	2,641,000	3,864,000	-5,387,000	2,131,000	4,346,000	363,000	-2,375,000	-673,000	1,321,000	2,345,000	-5,309,000	-260,000	1,818,000	456,000	-2,469,000	-702,000
other current assets	5,419,000	-10,256,000	-8,693,000	1,917,000	-2,526,000	772,000	404,000	1,973,000	1,935,000	-115,000	5,376,000	-2,939,000	3,158,000	12,180,000	-25,410,000	103,000	-918,000	4,226,000	-655,000	2,393,000	-2,879,000	3,463,000	1,515,000	749,000	2,366,000	-1,783,000	-1,705,000	1,059,000	-3,438,000	2,825,000	-11,089,000	4,593,000	2,617,000	2,945,000	-3,829,000	-2,719,000	-5,913,000	-1,477,000	702,000
other assets	2,308,000	1,337,000	-278,000	1,985,000	-1,706,000	86,000	-2,074,000	-1,997,000	673,000	221,000	818,000	-1,610,000	1,344,000	-342,000	2,482,000	-182,000	1,293,000	-331,000	-158,000	234,000	735,000	2,409,000	-3,961,000	-27,000	-2,561,000	-6,202,000	6,258,000	-1,575,000	645,000	-89,000	-202,000	559,000	-2,624,000	-3,139,000	733,000	-253,000	-1,571,000	-2,471,000	-1,331,000	-761,000	-543,000	-2,150,000	-80,000	-134,000	552,000	-606,000	-177,000
accounts payable and accrued expenses	-16,212,000	9,456,000	-23,094,000	-71,988,000	-26,802,000	-33,006,000	-60,754,000	37,099,000	-150,305,000	-9,557,000	16,927,000	2,394,000	-41,527,000	70,988,000	143,935,000	20,360,000	-11,455,000	103,278,000	11,046,000	8,551,000	-29,871,000	15,836,000	16,202,000	15,194,000	-32,420,000	2,949,000	9,843,000	16,265,000	-1,138,000	-7,816,000	12,580,000	-1,927,000	-16,916,000	-1,599,000	18,496,000	-13,356,000	22,794,000	-10,229,000	3,803,000	11,746,000	10,441,000	3,621,000	10,281,000	1,881,000	26,000	-6,063,000	2,765,000	1,245,000	-3,775,000	4,102,000	9,055,000	-7,147,000	-683,000	1,608,000	2,657,000	4,250,000	-3,752,000	505,000	5,901,000	-7,202,000	3,801,000	6,436,000	-872,000	-1,908,000	-3,830,000	247,000	-3,541,000	-860,000	361,000	5,981,000	301,000	298,000	-558,000	1,681,000	-2,309,000	-217,000	2,301,000	1,406,000	-649,000	-1,719,000	1,400,000	-236,000	-1,309,000	3,641,000	3,187,000	-1,609,000	-818,000	-544,000	-676,000	1,487,000
accrued compensation and benefits	-5,571,000	-13,995,000	4,772,000	4,912,000	-14,629,000	-6,365,000	-1,845,000	6,547,000	-13,799,000	-71,038,000	-13,443,000	-70,412,000	-23,137,000	96,486,000	32,569,000	31,565,000	116,000	64,985,000	18,226,000	8,817,000	844,000	-2,031,000	12,971,000	8,013,000	11,444,000	330,000	-762,000	5,546,000	9,475,000	-4,007,000	9,439,000	4,701,000	7,641,000	-8,351,000	8,381,000	-2,887,000	3,873,000	9,775,000	-4,819,000	11,367,000	4,344,000	996,000	2,890,000	8,529,000	-912,000	1,008,000	465,000	7,349,000	-2,522,000	-50,000	197,000	6,223,000	-694,000	68,000	595,000	-2,412,000	152,000	7,700,000	-4,783,000	1,266,000	-773,000	4,124,000	-5,377,000	-2,510,000	-4,787,000	-8,143,000	-5,105,000	1,121,000	1,528,000	3,214,000	-1,435,000	1,765,000	1,329,000	-1,222,000	-582,000	7,471,000	3,513,000	-25,000	-2,073,000	-6,445,000	-2,890,000	11,968,000	-7,292,000	3,633,000	-3,653,000	2,009,000	-3,407,000	2,680,000	-1,133,000	4,616,000
other liabilities	16,074,000	36,006,000	54,732,000	2,677,000	-7,266,000	-5,712,000	-62,751,000	1,616,000	38,984,000	11,903,000	-27,032,000	5,195,000	-123,082,000	18,353,000	148,953,000	-20,503,000	-14,804,000	9,039,000	12,048,000	6,828,000	29,658,000	-6,894,000	1,183,000	-1,421,000	-15,482,000	9,630,000	1,443,000	-3,835,000	-5,090,000	-1,498,000	-3,330,000	-5,637,000	-16,300,000	16,825,000	2,411,000	4,117,000	-12,460,000	14,079,000	2,262,000	-13,163,000	4,416,000	4,382,000	-9,113,000	3,478,000	798,000	349,000	398,000	1,500,000	2,665,000	-779,000	-3,044,000	1,771,000	-349,000	-2,097,000				-2,369,000	-451,000	-2,090,000	-214,000	-1,685,000	-2,154,000	2,423,000	-2,390,000	-1,406,000	1,110,000	1,789,000	58,000	1,482,000	3,569,000	1,734,000	959,000	206,000	-2,441,000	1,580,000	616,000	588,000	2,040,000	404,000	484,000	333,000	2,489,000	-1,682,000	6,000	458,000	-97,000	9,000		0
deferred revenue	4,902,000	2,076,000	-2,735,000	1,186,000	-151,000	360,000	-1,398,000	271,000	-1,471,000	2,040,000	-3,289,000	-915,000	232,000	-126,000	-1,956,000	2,694,000	-212,000	3,794,000	-1,087,000	40,000	-820,000	748,000	232,000	-13,000	-607,000	-1,418,000	-743,000	-511,000	1,625,000	-52,000	-1,226,000	-38,000	800,000	-84,000	476,000	2,299,000	-2,329,000	286,000	173,000	-674,000	2,346,000	-532,000
net cash from operating activities	78,548,000	92,671,000	72,814,000	66,703,000	99,515,000	81,386,000	-41,130,000	172,194,000	197,667,000	43,434,000	115,328,000	113,728,000	224,462,000	200,215,000	77,985,000	16,746,000	171,494,000	39,131,000	39,845,000	88,710,000	76,906,000	51,365,000	78,657,000	80,914,000	29,077,000	36,214,000	58,947,000	42,108,000	66,203,000	59,735,000	18,880,000	25,594,000	18,474,000	52,314,000	47,031,000	29,540,000	20,053,000	35,227,000	676,000	21,950,000	25,000,000	8,687,000	5,039,000	15,489,000	6,159,000	991,000	15,538,000	26,577,000	19,221,000	-2,699,000	18,450,000	11,512,000	20,997,000	9,553,000	6,513,000	4,881,000	2,354,000	5,564,000	4,849,000	21,501,000	-29,976,000	11,715,000	5,582,000	19,205,000	36,388,000	37,557,000	13,802,000	21,136,000	11,883,000	16,873,000	25,326,000	20,817,000	16,251,000	17,242,000	8,590,000	3,799,000	24,124,000	18,025,000	15,894,000	2,028,000	9,234,000	16,934,000	-1,778,000	19,929,000	998,000	17,447,000	25,029,000	21,671,000	9,019,000	31,598,000
cash flows from investing activities:
purchase and development of fixed assets	-9,800,000	-9,975,000	-16,220,000	-19,260,000	-27,266,000	-18,145,000	-29,856,000	-29,895,000	-26,449,000	-17,487,000	-24,602,000	-20,418,000	-17,221,000	-13,590,000	-14,863,000	-15,641,000	-11,462,000	-11,607,000	-10,345,000	-7,630,000	-6,156,000	-13,571,000	-10,442,000	-9,244,000	-8,144,000	-7,388,000	-11,284,000	-7,465,000	-10,754,000	-5,703,000	-9,361,000	-5,427,000	-6,243,000	-5,498,000	-4,251,000	-4,811,000	-6,276,000	-6,618,000	-5,888,000	-6,518,000	-8,234,000	-6,370,000	-4,847,000	-4,411,000	-4,033,000	-5,843,000	-2,600,000	-1,099,000	-3,133,000	-2,215,000	-1,719,000	-1,543,000	-1,209,000	-1,001,000	-1,098,000	-1,099,000	-764,000	-1,687,000	-1,783,000	-1,115,000	-599,000	-671,000	-612,000	-743,000	-1,204,000	-1,230,000	-1,653,000	-1,963,000	-2,527,000	-2,612,000	-2,660,000	-1,859,000	-2,501,000	-2,131,000	-2,997,000	-2,290,000	-2,886,000	-1,541,000	-762,000	-1,104,000	-1,181,000	-771,000
purchase of investments	-12,397,000	-21,722,000									0	-2,493,000	-6,641,000	-4,018,000	-28,282,000	-14,442,000	-7,696,000	-10,299,000	-10,893,000	-14,289,000	-18,650,000	-4,479,000	-9,550,000	-3,478,000	-5,919,000	-7,362,000	-6,639,000	-20,443,000	-4,656,000	-2,086,000	-4,075,000	-3,770,000	-2,447,000	-4,804,000
proceeds from sale and maturity of investments	0	7,239,000	3,400,000	1,207,000	3,285,000	1,207,000	0	2,907,000	4,980,000	2,007,000	1,835,000	3,464,000	2,200,000	6,885,000
payments to fund deferred compensation plan	-1,668,000	-1,588,000	0	-3,951,000	0	-4,461,000	0	-6,992,000	-959,000	-16,951,000	-107,000	-8,827,000	0	-12,584,000	-1,471,000	-4,703,000			0	-980,000	-720,000	-5,471,000	-1,143,000	-6,085,000	-1,696,000	-3,583,000	-2,117,000	-3,076,000	0	-4,724,000	-481,000	-3,232,000	-1,826,000	-4,998,000	-1,246,000	-2,603,000	-207,000	-2,855,000	-754,000	-98,000	-949,000	-1,203,000	0	-775,000	-184,000	-1,215,000
proceeds from settlements of company-owned life insurance policies
cash received for working capital settlement of prior year acquisition			0	0
net cash from investing activities	-20,591,000	-26,046,000	-14,203,000	-22,004,000	-22,332,000	-21,399,000	-323,731,000	-33,903,000	-22,428,000	-32,431,000	-22,643,000	-32,305,000	-92,523,000	-23,239,000	-28,385,000	-25,408,000	-56,403,000	2,794,000	-9,714,000	-15,196,000	-21,125,000	-492,137,000	-38,218,000	-12,915,000	-204,443,000	-36,248,000	-7,689,000	-32,698,000	-229,337,000	-9,613,000	-10,002,000	-3,823,000	-6,320,000	-13,301,000	-16,091,000	-8,117,000	-58,451,000	-174,703,000	-10,451,000	-10,768,000	-9,516,000	-85,350,000	-17,908,000	-4,511,000	-1,100,000	-4,709,000	-42,100,000	-503,000	-3,142,000	-2,155,000	-1,257,000	-2,103,000	-1,031,000	7,352,000	-1,142,000	-1,107,000	1,955,000	-1,687,000	-2,805,000	-3,835,000	462,000	-668,000	-22,887,000	-3,924,000	-1,204,000	-1,230,000	-1,819,000	-1,963,000	-11,064,000	-33,401,000	-2,656,000	-1,859,000	-7,983,000	-2,131,000	-2,997,000	-2,290,000	-2,886,000	-37,504,000	-111,859,000	-1,105,000	-1,591,000	-771,000	-1,070,000	-1,458,000	-1,955,000	-4,026,000	-4,772,000	-3,260,000	10,086,000	-3,715,000
cash flows from financing activities:
payments on revolving credit facility	-90,000,000	-95,000,000	-115,000,000	-120,000,000	-90,000,000	-50,000,000	-25,000,000	-110,000,000	-150,000,000	-70,000,000					0	0	-55,000,000	-15,000,000	-40,000,000	-80,000,000			-146,000,000	-50,000,000			-30,000,000	-5,000,000							-182,500,000				2,000,000	-10,000,000	-10,000,000	-7,000,000	0			-1,000,000	-15,000,000	0			0	0	0	-3,000,000						0			0	0	-6,500,000	-25,000,000	-5,000,000	0	-18,500,000	-11,500,000
proceeds from revolving credit facility	10,000,000	35,000,000	40,000,000	60,000,000	10,000,000	15,000,000	390,000,000	15,000,000	200,000,000	210,000,000					0	0	0	70,000,000	0	20,000,000	0	225,000,000	0	0	71,000,000	30,000,000	0	0							0	0	39,000,000	85,000,000	5,000,000	0	0	84,500,000	18,000,000			1,000,000	25,000,000	0	0	1,000,000		0	0	0	5,300,000	9,600,000	2,700,000	2,300,000									0	12,000,000	29,500,000	25,000,000
cash paid for shares withheld for taxes	-226,000	-1,211,000	-224,000	-469,000	-108,000	-3,973,000	-1,205,000	-2,522,000	-3,287,000	-6,134,000	-1,466,000	-3,835,000	-366,000	-9,431,000	-977,000	-527,000	-470,000	-5,258,000	-2,131,000	-158,000	-287,000	-4,353,000	-431,000	-1,809,000	-1,253,000	-10,280,000	0	-24,000	-482,000	-10,926,000	-302,000	-58,000	-1,701,000	-7,313,000	-227,000	0	-360,000	-5,194,000	-395,000	-195,000	-2,624,000	-8,694,000	-87,000	-118,000	-338,000	-3,905,000	-8,000	-125,000	-1,134,000	-1,403,000
net cash from financing activities	-80,226,000	-61,211,000	-79,898,000	-60,469,000	-80,108,000	-38,973,000	363,495,000	-105,022,000	-203,287,000	-44,457,000	-176,342,000	-3,835,000	-174,233,000	-237,455,000	-3,665,000	-527,000	-55,470,000	24,767,000	-55,071,000	-62,437,000	-127,132,000	456,126,000	159,000	-52,845,000	187,495,000	1,790,000	-44,263,000	-36,883,000	133,627,000	-14,970,000	-13,369,000	-24,951,000	-26,945,000	-11,928,000	-36,128,000	-26,817,000	36,268,000	152,967,000	4,910,000	-11,302,000	-12,563,000	75,155,000	16,166,000			-2,584,000	10,525,000	-4,856,000	-7,471,000	1,019,000		-21,029,000	-9,402,000	-15,923,000	-6,070,000	-7,087,000	-318,000	-1,825,000	-2,240,000	-20,462,000	-2,211,000	-1,536,000	21,721,000	-16,157,000	-28,420,000	-30,954,000	-8,296,000	-19,627,000	-345,000	5,934,000	-10,316,000	-30,319,000	-984,000	-9,304,000	-4,752,000	-2,817,000	-26,670,000	10,703,000	100,417,000	-1,035,000	-3,299,000	-9,563,000	-2,499,000	-23,076,000	-50,397,000	-841,000	-5,378,000	-29,853,000	-37,861,000	233,000
net increase in cash, cash equivalents and restricted cash	-22,269,000	5,414,000		-15,770,000	-2,925,000	21,014,000					-83,657,000	77,588,000	-42,111,000	-60,662,000	45,610,000	-9,178,000	59,624,000	66,668,000	-24,933,000	11,063,000	-71,409,000	15,307,000	40,657,000	15,286,000	12,040,000	1,655,000	7,053,000	-27,340,000	-29,416,000	35,133,000
cash, cash equivalents and restricted cash at beginning of period	0	89,305,000		0	0	108,273,000		0	0	137,872,000		0	0	246,714,000		0	0	83,990,000		0	0	153,962,000		0	0	84,324,000		0	0	98,894,000
cash, cash equivalents and restricted cash at end of period	-22,269,000	94,719,000		-15,770,000	-2,925,000	129,287,000		33,269,000	-28,048,000	104,418,000		77,588,000	-42,111,000	186,052,000		-9,178,000	59,624,000	150,658,000		11,063,000	-71,409,000	169,269,000		15,286,000	12,040,000	85,979,000		-27,340,000	-29,416,000	134,027,000
supplemental disclosures of cash flow information:
cash paid for amounts included in the measurement of operating lease liabilities	2,153,000	2,138,000	2,510,000	2,579,000	2,460,000	2,805,000	2,420,000	1,962,000	2,319,000	2,610,000	2,637,000	2,778,000	3,692,000	4,230,000	4,799,000	25,326,000	4,846,000	4,894,000	4,973,000	4,967,000	5,378,000	4,734,000	4,523,000	4,600,000	4,356,000	4,338,000
cash paid for interest	20,661,000	2,939,000	22,909,000	5,400,000	25,182,000	7,543,000	23,014,000	2,435,000	21,599,000	1,053,000	18,568,000	63,000	18,691,000	196,000	18,784,000	273,000	18,708,000	320,000	8,804,000	1,089,000	10,861,000	1,898,000	8,742,000	3,274,000	10,190,000	1,524,000	9,762,000	1,354,000	9,966,000	201,000	8,541,000	266,000										1,330,000				1,588,000				2,399,000		2,925,000	3,547,000	4,520,000			4,507,000	4,626,000			1,803,000	1,825,000	2,667,000	1,398,000	1,598,000	1,724,000	2,448,000	2,271,000	2,340,000	2,541,000	2,852,000	2,954,000	3,023,000	2,996,000	3,241,000	3,543,000	3,628,000	3,488,000	2,810,000	1,366,000	1,401,000	1,493,000	1,617,000	1,714,000	1,817,000	96,000	0	90,000	64,000	65,000	63,000	62,000
cash paid for income taxes	9,085,000	2,139,000	6,477,000	4,095,000	13,271,000	4,309,000	67,423,000	1,097,000	4,332,000	5,404,000	49,050,000	44,097,000	110,836,000	9,824,000	33,516,000	28,802,000	38,495,000	5,566,000	15,531,000	30,668,000	14,000	45,000	5,290,000	5,088,000	23,177,000	4,192,000	9,370,000	6,818,000	11,674,000	2,731,000	7,748,000	20,834,000														223,000				4,876,000		49,000	198,000	116,000		335,000	835,000	336,000		-56,000	165,000	761,000	551,000	3,366,000	684,000	1,008,000	6,057,000	7,370,000	13,098,000	6,422,000			110,000	884,000			708,000	2,194,000	618,000	2,378,000	2,127,000	1,231,000	1,647,000	127,000	3,278,000	2,595,000	9,153,000	2,359,000	8,374,000	589,000	7,575,000	326,000
supplemental disclosures of non-cash investing and financing activities:
purchase of fixed assets recorded in accounts payable and accrued expenses	-4,047,000	5,405,000	-6,391,000	1,552,000	-4,740,000	12,777,000	-6,711,000	3,913,000	4,079,000	6,849,000	456,000	-2,375,000	2,791,000	4,771,000	-1,361,000	1,415,000	-123,000	3,788,000	2,096,000	-218,000	-561,000	1,786,000	159,000	-210,000	-214,000	2,566,000	-2,798,000	2,704,000	-1,060,000	2,860,000	-194,000	917,000
right-of-use assets obtained in exchange for operating lease liabilities	0	544,000	74,000	495,000	2,136,000	2,338,000	10,766,000	-420,000
net income on investments in available-for-sale securities		4,000	3,000	20,000	113,000	64,000		73,000	74,000	81,000
change in fair value of contingent consideration liabilities							0	0	2,350,000	80,000
goodwill impairment losses
proceeds from sale of equity investment							0				0	0	0	68,000	0				224,000
cash paid for acquisitions, net of cash and restricted cash received											231,000	0			0	0			0	0	-99,000	-476,392,000
cash paid for other intangibles											0	-4,031,000			0	0			0	0	0	-1,400,000	-120,000	0	-1,030,000	-90,000	0	0
payments on loans payable
repurchase of common stock							0	0	-250,000,000	-174,744,000	-174,876,000	0	-173,867,000	-228,024,000									0	0	-775,000	-17,930,000	-14,263,000	-31,859,000			-13,067,000	-6,768,000																																			0	-21,998,000			0				0	0										-2,485,000	-4,968,000	-31,035,000
payment of excise tax on share repurchases
payment of financing costs							0	0	0	-3,579,000									-4,610,000	-2,717,000	-282,000	-3,899,000	-4,348,000	-98,000			0	0	0	-2,331,000					-6,113,000	0	0	-448,000					0	0			571,000	0			0	-40,000			0				66,000	-3,695,000			-4,415,000	1,000			0	0							3,000	-21,000			-4,822,000	0			0		-3,644,000	-29,000	0	-955,000	-63,000	-21,000	0	-17,000
earn-out payments to settle contingent consideration liabilities for prior acquisitions							0								0	0
net decrease in cash, cash equivalents and restricted cash								33,269,000	-28,048,000	-33,454,000
cash, cash equivalents and restricted cash at beginning of year
cash, cash equivalents and restricted cash at end of year
acquisitions:
fair value of tangible assets acquired in acquisitions, net of cash and restricted cash received											-127,000	0			0	-4,000			29,000	-164,000	-1,372,000	37,240,000		868,000
goodwill											-311,000	0			-942,000	409,000			-5,456,000	-133,000	18,586,000	255,974,000	8,941,000	-1,846,000	123,447,000	26,494,000	207,000	-835,000																											411,000				-2,125,000								0	0	0	11,557,000	-488,000	0							104,885,000	1,000									0	-53,000
intangible assets											0	0			0	0			0	0	-24,000,000	252,000,000	9,000,000	2,400,000	89,300,000	6,880,000	-1,000	1,000																											0				3,639,000								0	0	0	13,960,000	0	0
liabilities assumed											207,000	0			942,000	-405,000			5,427,000	297,000	6,885,000	-68,822,000	3,725,000	-1,349,000	-30,134,000	-3,390,000	-206,000	-302,000																																							166,000	-166,000	-3,000	-1,004,000	0	0							-57,504,000	0									0	73,000
contingent consideration liabilities											0	0
net cash paid for acquisitions											-231,000	0			0	0			0	0	99,000	476,392,000	19,684,000	73,000	198,624,000	29,525,000	-1,000	-686,000																																							166,000	0			-4,000	0																	0	27,000
excise tax payable on share repurchases							-38,000	219,000	1,964,000	1,556,000
write-off of fees on credit facilities and senior notes															0	0	0	158,000
restricted investments balance															333,000	-3,000	-3,000	22,000	-3,000	6,000	-15,000	21,000	-21,000	6,000	57,000	36,000	-6,000	-93,000	19,000	-12,000
purchase of equity investment																0	0	-500,000
cash paid for initial direct costs
payments on term loans															0	0	0	-21,875,000	-25,000,000	-201,562,000			-149,062,000								0	-18,125,000	-25,000,000	-938,000
effect of exchange rate changes on cash														-183,000	-325,000	11,000	3,000	-24,000	7,000	-14,000	-58,000	-47,000	59,000	132,000	-89,000	-101,000	58,000	133,000	91,000	-19,000	13,000	-73,000	-42,000	4,000	102,000	40,000	86,000	39,000		54,000	-80,000	68,000	113,000			-9,000		-84,000	-28,000	93,000		-55,000	33,000	-43,000	18,000	32,000	-1,000	-1,000	2,000	27,000	4,000	3,000	16,000	9,000	49,000	-14,000	-176,000	-97,000	47,000	-66,000	-29,000	4,000	22,000	-8,000	70,000	-69,000	0	-14,000	-81,000	13,000	-24,000	10,000						-60,000
change in fair value of contingent consideration											-1,740,000	-1,770,000							6,600,000	-6,700,000	4,800,000	200,000	4,895,000	4,441,000	-1,458,000	-700,000	-1,093,000	-1,326,000			118,000	20,000	23,000	23,000	64,000	-302,000	115,000	99,000	-30,000
loss on disposal or sale of fixed assets											989,000	92,000	238,000	241,000	2,321,000	3,000	30,000	353,000	658,000	343,000	55,000	3,266,000	35,000	410,000	35,000	4,000	77,000	1,000	34,000	5,000	97,000	87,000	-22,000	65,000	24,000	22,000			1,000				10,000	46,000	3,000	1,000	1,000	5,000	0	8,000	16,000	2,000	14,000	0	8,000	27,000	28,000	45,000	15,000	43,000	59,000	6,000	17,000	902,000	31,000	29,000	87,000	67,000	23,000	50,000		0	5,000	24,000									76,000	-2,000
purchase of convertible promissory notes																			0
cash received for working capital adjustments for prior year acquisitions																			0	0	0	66,000
proceeds from term loans																				0	0	250,000,000		0
proceeds from senior notes																			350,000,000
redemption of senior notes
net gain on investments														174,000
net income on deferred compensation balances															-76,000	-149,000			848,000	419,000
amortization of discount on investments															-11,000	-6,000	-5,000	-30,000	-13,000	-25,000	-21,000	-50,000	-22,000	-47,000	-109,000	-120,000	-124,000	-16,000	-47,000	-15,000	-15,000	-70,000
purchase of equity investments
proceeds from maturity of investments																9,300,000	5,500,000	25,200,000	11,300,000	7,400,000	4,500,000	9,600,000	3,500,000	5,965,000	10,970,000	11,700,000	14,600,000	2,200,000	5,300,000	2,900,000	3,101,000	9,000,000	6,200,000	2,000,000
earn-out payments for prior acquisitions																		-3,100,000	0	0	0	-10,622,000	0	0			0	0	0	-1,713,000	0	0	0	-3,677,000
proceeds from term loan																																			0	0	0	75,000,000					0
earn-out liabilities																							-3,100,000	0	-10,622,000	-1,500,000	0	0
write-off of fees on credit facilities
purchase of convertible promissory note																					0	-490,000
increase in allowances for doubtful accounts and sales credits																							-534,000	1,831,000	2,370,000	2,608,000	2,766,000	1,431,000	2,552,000	2,257,000	1,327,000	1,272,000	2,332,000	5,408,000	5,262,000	1,294,000	2,765,000	2,687,000	1,369,000	1,240,000	1,883,000	2,192,000	1,478,000	762,000	1,710,000	443,000	1,949,000	1,031,000	546,000	1,102,000	1,484,000	1,849,000	1,447,000	2,006,000				1,084,000				439,000
equity investment																											-1,500,000				0	0
cash paid for acquisitions, net of cash received																							-19,684,000	-73,000	-198,624,000	-29,525,000	1,000	686,000							59,000	-203,000	-51,120,000	-165,230,000	-2,984,000
cash paid for other liabilities, working capital adjustments and holdback liability for prior year acquisitions
proceeds from termination of derivative contract																																0
fair value of tangible assets acquired in acquisitions, net of cash received																										1,041,000	-1,000	450,000
write-off of fees on the prior credit facilities																											0	0
excess tax benefit from equity awards vested and exercised
capital lease repayments																																			-1,000	-4,000			0	0	0	-4,000	-57,000	-159,000	-157,000	-156,000	-202,000	-161,000	-160,000	-158,000	-158,000	-162,000	-162,000	-168,000				-166,000					-339,000	-167,000			-176,000	-165,000	-163,000	-163,000	-159,000	-158,000	-157,000	-157,000	-177,000	-144,000	-118,000	-105,000	-103,000	-106,000	-73,000	-82,000	-99,000	-72,000	-81,000	-85,000	-69,000	-69,000	-73,000	-73,000	-68,000	-30,000
proceeds from termination (payment on reduction) of derivative contract
holdback provision																																																																			0	0	0	-2,336,000
cash paid for working capital adjustments and holdback liability for prior year acquisitions																																			-500,000	-500,000
loss on debt extinguishment																														574,000													0	0			0				0	0
restricted cash, cash equivalents and investments balance																															-30,260,000	-6,264,000	-8,448,000	4,951,000	7,088,000					-3,727,000	-1,926,000	-205,000	36,000	-3,081,000	-3,082,000	-2,875,000	-1,076,000	-1,075,000
change in restricted cash, cash equivalents and investments balance																															1,314,000	606,000	-4,000	-1,000									1,409,000	2,675,000	4,117,000	4,349,000	0	-4,000	-9,000	60,000
proceeds from exercise of equity awards																																							0	310,000	154,000	3,199,000	0	1,734,000	0	58,000	3,000	407,000	56,000	711,000										0			0	0			-6,000	584,000			-1,000	209,000
net increase in cash and cash equivalents																															-4,478,000	-3,253,000	-14,833,000	27,089,000		-5,354,000	-2,044,000	13,530,000		-66,000								21,134,000	8,580,000	-3,742,000		-11,675,000	10,597,000	939,000	-681,000	-3,281,000	3,990,000	2,051,000	-194,000	-39,291,000	4,801,000	9,514,000	4,432,000	-867,000	6,813,000	5,359,000	3,511,000	-551,000	521,000	-10,660,000	12,325,000	-11,357,000	7,306,000	5,799,000	911,000	-1,377,000	-5,432,000	-8,790,000	4,371,000	-99,000	4,320,000	6,610,000	-5,299,000	-4,624,000	-51,390,000	12,570,000	14,874,000	-11,502,000	-18,756,000	28,116,000	5,487,000	9,634,000
cash and cash equivalents at beginning of year																																																		5,681,000
cash and cash equivalents at end of year																																																		1,939,000
excess tax benefits from share-based compensation																																				0	-442,000	-2,322,000		-458,000	-1,782,000	-5,029,000		-64,000	-170,000	-1,546,000		-98,000	-727,000	-704,000
excess tax benefits from equity awards vested and exercised
cash and cash equivalents at beginning of period																																0	0	10,622,000		0	0	9,576,000			0	13,073,000				15,580,000		0				0	0	3,962,000		0	0	1,883,000		0	0	27,053,000		0	0	11,316,000		0	0	18,495,000		0	0	4,422,000		0	0	19,110,000		0	0	3,908,000		0		0	0	40,135,000		0	0	15,654,000
cash and cash equivalents at end of period																																-3,253,000	-14,833,000	37,711,000							2,841,000	11,633,000				9,269,000		21,134,000				-11,675,000	10,597,000	4,901,000		-3,281,000	3,990,000	3,934,000		-39,291,000	4,801,000	36,567,000		-867,000	6,813,000	16,675,000		-551,000	521,000	7,835,000		-11,357,000	7,306,000	10,221,000		-1,377,000	-5,432,000	10,320,000		-99,000	4,320,000	10,518,000		-4,624,000		12,570,000	14,874,000	28,633,000		28,116,000	5,487,000	25,288,000
equity method investment																																											0	-2,000,000	-1,000,000	-2,000,000
earn-out payment for prior acquisition																																			0	0	0	-900,000
payment on reduction of derivative contract
net change in cash and cash equivalents
liabilities and deferred revenue assumed
adjustments to reconcile net income to net cash from operating activities, net of acquisitions:
equity method investment in pipeline health holdings llc
payments on term loan																																				-2,813,000	-2,812,000	-2,813,000	-1,875,000	-1,875,000	-1,875,000	-1,875,000	-1,875,000
restricted cash and cash equivalents balance																																					-1,314,000	176,000
loan to pipeline health holdings llc																																										-667,000
cash paid for working capital adjustments for prior year acquisition
holdback settlement in equity from prior acquisition																																															0	0
change in restricted cash and cash equivalents balance																																																								-8,000			0	0	1,061,000	3,000
proceeds from sales of assets held for sale																																															0				406,000	22,000	272,000	8,350,000
prepaid expenses and other current assets																																									-5,258,000	-3,063,000	2,171,000	-1,182,000	-48,000	-954,000	843,000	1,720,000	5,897,000	-2,436,000	-4,779,000	-618,000	1,746,000	-5,033,000	-445,000	898,000	1,447,000	-2,725,000	-429,000	966,000	5,387,000	-4,739,000	1,078,000	2,248,000	2,183,000	463,000	-83,000	1,242,000	-646,000	-3,092,000	1,038,000	397,000	676,000	-1,541,000	821,000	-1,095,000	3,322,000	-1,046,000	1,161,000	-384,000	1,416,000	-364,000	1,171,000	-253,000		1,988,000	1,230,000	-3,617,000
convertible loan to pipeline health holdings llc
cash paid for acquisition, net of cash received																																									0	-76,945,000																										0				0				0				-1,000
cash paid for working capital adjustments for prior acquisition																																									0	-165,000
(gain) loss on disposal or sale of fixed assets																																										-2,000																																					45,000	7,000	2,000	-63,000
net decrease in cash and cash equivalents																																										-1,440,000				-6,311,000
excess tax benefit from share-based compensation
gain on sale of discontinued operations
changes in assets and liabilities, net of effects from acquisition and divestiture:
prepayment penalty associated with the prior credit facilities																																																			0	0
changes in assets and liabilities:
change in bank overdraft																																														-127,000	169,000	-75,000	-25,000	165,000		3,201,000	-895,000	-2,290,000			640,000	-913,000										-2,329,000				-1,737,000	772,000	-9,485,000		-6,754,000	327,000	7,119,000		0	0	-1,093,000				1,705,000	-341,000	2,206,000		389,000	304,000	1,426,000
repayments on prior term loan
payments on current term loan
proceeds from current term loan
proceeds from prior revolving credit facility
repayments on prior revolving credit facility
proceeds from current revolving credit facility
payments on current revolving credit facility
non-cash interest expense																																															286,000	-60,000	815,000	295,000	575,000	801,000	393,000	1,152,000	958,000	967,000	926,000	936,000	918,000	770,000	767,000	785,000	2,738,000	773,000	705,000	367,000		427,000	362,000	420,000		417,000	334,000	485,000		665,000	952,000	1,030,000		232,000	400,000	255,000				93,000	109,000	109,000		86,000
impairment charges for discontinued operations
write-off of assets due to discontinued operations
cash payment for holdback liability for prior year acquisitions
cash paid for acquisitions
payments on term loan credit facility																																															0	-5,000,000
proceeds from term loan credit facility, net of discount
repayments of prior notes payable																																																			0	0
changes in assets and liabilities, net of effects from divestiture:
deposits and other assets																																																	-1,448,000	-1,608,000	-816,000	-1,247,000	520,000	-1,377,000	-115,000	271,000	-251,000	-152,000	-406,000	-260,000	183,000	-428,000	-96,000	-991,000	-323,000	2,381,000	1,065,000	-2,950,000	-519,000	-284,000	-167,000	-602,000	-674,000	-1,082,000	-819,000	-841,000	4,779,000	-889,000	228,000	-970,000	-688,000	-33,000	-326,000	76,000
stock-based compensation																																																		1,702,000	1,646,000	1,569,000	1,577,000	1,432,000	1,723,000	1,697,000	1,723,000	1,989,000	1,940,000	1,955,000	2,040,000	2,349,000	1,948,000	1,931,000	2,155,000	2,675,000	2,391,000	2,426,000	2,382,000	2,123,000				1,795,000
payments on notes payable																																																						-9,815,000	-4,625,000	-4,625,000	-2,312,000	-2,313,000	-2,312,000	-2,387,000	-1,375,000	-1,375,000	-77,270,000	-12,712,000	-23,050,000	-1,784,000	-6,645,000	-7,737,000	-3,769,000	-14,001,000	-10,140,000	-10,152,000	-2,691,000	-3,860,000	-27,260,000	-10,585,000			-93,325,000	-1,089,000	-1,088,000	-11,716,000	-3,493,000	-23,284,000
excess tax benefit from stock options and sars exercised and rsus vested																																																																			7,000	-18,000			18,000	-29,000
impairment charges for continuing operations
payment of prior notes payable discount
payments on new term loan credit facility																																																			-12,000,000	-24,000,000
proceeds from new term loan credit facility, net of discount																																																			0	0
proceeds from prior notes payable
net settlement of employee equity awards																																																								-41,000	-1,271,000	-734,000		-34,000
payment on nf investors, inc. (“nfi”) then-existing debt
excess tax benefits from sars exercised and rsus vested and issued
impairment charges																																																											1,050,000	49,782,000			0	0	0	175,707,000
gain on sale of discontinued operations, net of tax																																																				0	0	-1,187,000
change in restricted cash and cash equivalents and investments balance																																																				-582,000	-94,000	3,000
payments of employee tax withholdings from equity transactions																																																				-29,000	-187,000	-656,000									0
excess tax benefit from sars exercised and rsus vested and issued																																																												0
excess tax benefits from rsus vested and issued
excess tax benefit from rsus vested and issued																																																					17,000	-6,000
changes in assets and liabilities, net of effects from divesture:
payment of notes payable discount																																																							0				0
proceeds from notes payable																																																							0				0
payments on termination of derivative contracts
change in bank overdraft, net of overdraft acquired																																																							-1,264,000				422,000				0	-3,274,000	3,274,000	-3,995,000				6,598,000
cash (received) paid for income taxes
supplemental disclosures of noncash investing and financing activities:
fixed assets acquired through capital leases																																																												0			0	0	163,000	1,982,000	179,000	0	38,000	26,000	118,000	17,000	137,000	46,000	0	43,000	679,000	71,000	0	-15,000			0
fair value of assets acquired in acquisitions, net of cash received																																																																						8,778,000																			-8,000	7,000
nfi then-existing debt
preferred stock issued																																																							0				263,000
common stock issued																																																							0				0
increase in allowance for doubtful accounts and sales credits																																																								935,000				1,856,000
excess tax benefit from sars exercised and rsus vested																																																								-202,000
changes in assets and liabilities, net of effects from acquisition:
other liabilities and deferred revenue																																																								-907,000
cash payment for holdback liability for prior acquisitions
capital lease payments																																																								-169,000				-162,000	-159,000	-161,000				-175,000
payment of revolving credit facility
payments on nf investors, inc. (“nfi”) then-existing debt
cash paid for interest, including financing costs
fair value of assets acquired in acquisition, net of cash received																																																																								0								0
nfi then-existing debt assumed
other liabilities assumed
net cash paid for acquisition																																																																						30,789,000										1,000
excess tax benefits from sars exercised and rsus vested
excess tax benefits from stock options and sars exercised and rsus vested																																																										-1,000
income taxes payable																																																																			1,272,000	0	-3,162,000	237,000	-1,317,000	-2,452,000	7,808,000	3,522,000	14,533,000	444,000			-11,175,000	607,000	-633,000	734,000			-4,424,000	3,482,000	-3,479,000	4,865,000	-7,093,000
purchase of intangible assets																																																																			0	0
payment on nfi then-existing debt
deferred tax liability																																																																							484,000	0
excess tax benefit from stock options and stock appreciation rights (“sars”) exercised and rsus vested
income tax receivable
excess tax benefit from stock options and sars exercised and rsus vested and issued
fair value of tangible assets acquired in acquisition, net of cash received
adjustments to reconcile net income to net cash from operating activities, net of effects from acquisitions:
cash payment for holdback liability for 2005 acquisition																																																																			0	0
payment of employee tax withholdings from equity transactions
excess of net working capital payable
cash paid for acquisition																																																																						-30,789,000
excess net working capital payable																																																																						-166,000
noncash interest expense																																																																																			248,000	711,000
payment on termination of derivative contract
change in bank overdraft, net of effects of acquisition
issuance of treasury stock for acquisition earn-out
benefit from bad debts																																																																				980,000	1,167,000	1,435,000	1,567,000	1,034,000	502,000	588,000	687,000	759,000	1,019,000	344,000							-356,000	18,000	-6,000	29,000	23,000	849,000
excess tax benefit from stock options exercised
proceeds from stock options exercised
net change in foreign currency translation adjustment and unrealized loss on derivative financial instruments, net of tax																																																																						-749,000
adjustments to reconcile net income to net cash from operating activities, net of effects from acquisition:
proceeds from issuance of notes payable																																																																											1,600,000	0						2,500,000
net change in foreign currency translation adjustment and unrealized gain on derivative financial instruments, net of tax																																																																							-521,000	-555,000	292,000	-265,000	177,000	-1,654,000	736,000	1,137,000	-570,000	79,000	-196,000	162,000	247,000	-235,000
earn-out liability
treasury stock issued
non-cash stock-based compensation																																																																								2,266,000			1,788,000	1,857,000	1,791,000	1,367,000	21,000	40,000	41,000	40,000	95,000	218,000	219,000	218,000	219,000	218,000		219,000
cash paid (received) for income taxes
issuance of treasury stock for acquisition earnout																																																																											0	-7,000	0	10,667,000
excess tax benefit from stock option exercises																																																																										-3,132,000	-15,807,000	4,415,000	1,677,000	483,000
cash paid for acquisition earnout																																																																														-35,963,000
proceeds from issuance of common stock																																																																										1,066,000				3,206,000		160,000	988,000	828,000		538,000
proceeds from exercise of stock options																																																																											8,810,000	10,272,000
gain on disposal or sale of fixed assets																																																																												45,000
issuance costs of common stock																																																																																0
benefit from (recovery of) bad debts																																																																															835,000	241,000	460,000	202,000
stock-based compensation in connection with tender offer
cash paid under deferred purchase agreement																																																																																					0	0
repurchase of common stock and options, including transaction costs
proceeds from issuance of common stock, net of issuance costs																																																																																					-1,000				-1,080,000	994,000
accrued earn-out
repurchase of common stock and options
noncompete covenants																																																																																0									8,000	0
proceeds from sale of short-term investments
(recovery of) benefit from bad debts																																																																																				307,000
purchase of fixed assets																																																																																				-1,458,000	-1,955,000	-4,026,000	-3,772,000	-3,260,000	-1,030,000	-1,166,000	-1,184,000	-948,000
cost of repurchase of common stock into treasury																																																																																				0
effect of exchange rate changes on cash and cash equivalents																																																																																				-19,000
fixed assets obtained through capital leases																																																																																						126,000	72,000	8,000		40,000	1,196,000	26,000
loss on extinguishment of debt
income taxes receivable and other current assets																																																																																									-279,000	-4,619,000
deposits																																																																																					-47,000	-14,000	-77,000	-85,000	-64,000	-76,000
due to former shareholder
purchase of short-term investments
change in bank overdraft, net of effects of acquisitions
accrued interest on notes payable converted to notes payable
earnout provision accrual
deferred income tax benefit																																																																																						0	1,600,000	750,000
gain on disposal of fixed assets
changes in assets and liabilities, net of effects from acquisitions in 2002:
proceeds from maturity of short-term held-to-maturity investments																																																																																										-1,522,000
acquisitions, net of cash acquired																																																																																										-27,000
offering costs
effect of exchange rates changes on cash																																																																																						-10,000
non-compete covenants
extraordinary loss on extinguishment of debt
present value of deferred purchase payments
loss on disposal of fixed assets
cash paid for deferred purchase agreement
accrued interest on notes payable converted to additional notes payable
deferred income taxes
adjustments to reconcile net income to net cash provided by operating activities:
proceeds from maturity of short-term held-to-maturity investments																																																																																												4,148,000
costs of issuance of common stock																																																																																												-63,000
supplemental disclosures of non-cash investing and financing activities:
accrued interest on notes payable converted to additional notes payable
purchase of short-term held-to-maturity investments
acquisitions, including acquisition costs
proceeds from issuance of common stock, net of issuance costs
change in bank overdraft, net of effects of acquisitions
net increase in cash and cash equivalents
supplemental disclosures of noncash investing and financing activities:
common stock issued in exchange for minority interest
accrued interest on notes payable converted to notes payable
fair value of assets acquired in acquisitions, net of cash received

We provide you with 20 years of cash flow statements for AMN Healthcare Services stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AMN Healthcare Services stock. Explore the full financial landscape of AMN Healthcare Services stock with our expertly curated income statements.

The information provided in this report about AMN Healthcare Services stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.